Vascular surgeons interested in how to build a stem cell program should plan to attend the upcoming 27th Annual Vascular Research Initiatives Conference (VRIC). Designed to encourage interaction and collaboration between vascular surgeon investigators and scientists from other vascular biology-related disciplines, this year the VRIC is offering a special translational scientific session, “How to Put Together a Stem Cell Program for Therapeutic Angiogenesis: Challenges and Pitfalls.”
“There are new reports showing the value of these stem cell programs and there are many ways to do them,” said Alan Dardik, MD, PhD, VRIC Course Director.
Dr. Alan Dardik
“Instead of reading about these programs in an abstract way in the scientific journals, attendees can learn about stem cell programs firsthand, from experts that are currently performing this type of therapy, and ask their detailed and specific questions in a small group format.”
Experts in the field of stem cell research, all of whom have done stem cell therapy in human patients, have been selected as speakers by the SVS Research and Education Committee and the ATVB Program Committee. These speakers include: Drs. Michael Murphy, Omaida Velazquez, Douglas LoSordo and Richard Powell.
In addition to the translational session, VRIC, to be held April 30 Orlando, Florida, provides an opportunity for vascular surgeon investigators and vascular biologists to participate in this unique scientific collaborative prior to the Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) Scientific Sessions.
VRIC is aimed at vascular surgeons, vascular biologists, physicians with an interest in vascular disease, vascular surgery trainees, research trainees in vascular surgery and vascular biology, and industry personnel with an interest in vascular disease.
Abstracts can be submitted for VRIC until the Jan. 25 deadline. Selected high-impact abstracts that are presented at the VRIC session may also be invited for presentation by the principal investigator at the SVS 2013 Vascular Annual Meeting®, May 30 – June 1.
“Anyone with an interest in vascular biology and vascular surgery should be at VRIC,” Dr. Dardik said. “Since one of the objectives of VRIC is to stimulate interest in research among aspiring academic vascular surgeons, trainees are especially welcome.”
Plan to attend, experience, and contribute to this unique collaborative scientific environment while earning up to 7 AMA PRA Category 1 CreditsTM. For more information, visit VascularWeb.org.
